Protecting Intellectual Property of Innovative Healthcare Compliance Analytics
As part of its fundamental commitment to innovation, Protenus is pleased to announce the recent grant of US Patent No. 11,295,844 titled “Methods and Systems for Analyzing Accessing of Drug Dispensing Systems.” With this patent, Protenus now holds a number of granted US patents covering various key aspects of patient privacy monitoring and drug diversion surveillance technologies, along with several other pending US and foreign patent applications.
Protenus’ privacy monitoring patents cover various techniques for determining patient data access events that constitute possible breaches of patient data. For example, these patents include numerous techniques such as retrieving HR data, tagging data access events, determining associations between employees within clinical groups, and displaying alerts related to possible breaches.
Protenus’ drug diversion patents cover various techniques for detecting anomalous drug dispensing events. Covered techniques include clustering dispensing events into groups, determining dispensing patterns, displaying alerts for outlier dispensing events, and determining confidence levels associated with alerted outlier events, among other things.
These patents demonstrate Protenus’ determination to protect its intellectual property in the healthcare compliance analytics space. “Protenus has been a leader in healthcare analytics, and we are taking deliberate steps to protect our intellectual property,” said Nick Culbertson, CEO and Co-Founder. “Our continued dedication also allows us to deliver innovative solutions to our hospital customers that help them reduce risk.”
